Skip to content

The association between aging or chronic diseases and mitochondrial oxygenation and oxygen consumption as measured with the Protoporphyrin IX Triplet State Lifetime Technique

The association between aging or chronic diseases and mitochondrial oxygenation and oxygen consumption as measured with the Protoporphyrin IX Triplet State Lifetime Technique - Aging, chronic disease, mitoPO2 and mitoVO2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51166
Enrollment
319
Registered
2021-05-21
Start date
2021-05-27
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Veroudering aging seniority

Interventions

None listed

Sponsors

Anesthesiologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Aged between 18 years of age and 90 years of age - Acceptable proficiency of the Dutch language - Healthy volunteers without physical or mental illness Comorbidity group In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Aged between 18 years of age and 90 years of age - Acceptable proficiency of the Dutch language - One of the underlying illnesses: neurodegenerative disease, diabetes mellitus type II or obesity (BMI>30), no other relevant comorbidity

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Porphyria - Known intolerance to components of the ALA plaster - Presence of mitochondrial disease - Pregnancy/lactation - Patients with skin lesions on the measurement location which impede measurements - Incapability to provide inform consent, due to a mental condition interfering with the ability to understand the provided information

Design outcomes

Primary

MeasureTime frame
MitoPO2 (mmHg). Ten mitoPO2 (mmHg) baseline measurements will be performed on both the sternum and upper arm of all subjects. The mean and standard deviation of those measurements will compute the baseline mitoPO2 for every participant.

Secondary

MeasureTime frame
MitoVO2 (mmHg/second). Applying pressure on the probe will cause a temporary halt of circulation to the mitochondria. As the oxygen consumption continues, this will result in a time-dependent decrease in mitoPO2 from which the mitoVO2 can be calculated in mmHg/second. Three mitoVO2 measurements will be performed on both the sternum and the upper arm and the mean will be calculated for both.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)